TCL Archive Neutron Therapy “Treatment Of Choice” In Salivary Gland Tumors – 100 Percent Complete Reponses June 13, 1986
TCL Archive HHS lawyer tells of pressure to allow former NCI Director Richard Klausner to receive $40,000 prize. May 21, 2004
TCL Archive Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer January 25, 2008
TCL Archive Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines. March 31, 2000